Physician profile
Karl E Reiber
NPI 1770846784
$1,248.91
in general payments reported to CMS, 2019-2025
13 companies · $106 in 2025
The $106 reported for 2025 was more than what a typical Pediatrics provider received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $266 · 2020: $97.71 · 2021: $215 · 2022: $241 · 2023: $169 · 2024: $154 · 2025: $106.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $429.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $428.93 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $323.17 | 2019-2025 | Bexsero, Rotarix, Shingrix |
| Merck Sharp & Dohme LLC | $318.10 | 2019-2025 | Gardasil 9, Vaxneuvance, Vaxelis |
| Sanofi Pasteur INC. | $276.30 | 2019-2024 | |
| Cranial Technologies, INC | $92.47 | 2021-2024 | Doc Band |
| Sobi, INC | $69.70 | 2021-2023 | |
| Lilly USA, LLC | $42.12 | 2019-2023 | Trulicity, Mounjaro |
| Seqirus USA INC | $25.18 | 2025 | Fluad, Flucelvax |
| Pfizer INC. | $24.07 | 2023 | |
| Exact Sciences Corporation | $22.29 | 2025 | The Cologuard Plus Collection Kit |
| Hologic Sales and Service, LLC | $15.49 | 2019 | |
| Abbvie INC. | $15.02 | 2024 | |
| Phadia US INC. | $13.78 | 2024 | Immunocap |
| Novartis Pharmaceuticals Corporation | $11.22 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Karl Reiber listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.